Nutranomics Announces Exclusive Shareholder Product Promotion

Jan 14, 2014, 04:00 ET from Nutranomics, Inc.

DRAPER, Utah, Jan. 14, 2014 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company's direct-to-consumer division has been authorized to allow shareholders of NNRX stock to purchase all products listed on the website at a special 50% discount.

"My main goal when I created this company was to help as many people as possible to achieve ultimate health and wellbeing.  I can't think of a better way to start off the New Year than extending a special product discount offer to our many shareholders," stated Dr. Tracy K. Gibbs, CEO of Nutranomics.  "Our shareholders are an important part of the Nutranomics family, and like our many employees, should enjoy the same significant product discounts to help them reach their health goals in 2014."

Nutranomics has assigned the toll-free number (800) 745-0393 for shareholders to call and order products at the exclusive 50% discount.  There is no limit on order quantity or repeat orders.  Shipping and all sales tax still apply.

Dr. Gibbs concluded, "I encourage all of our shareholders to call and take advantage of this exclusive offer."

About Nutranomics

Nutranomics is a publicly traded company engaged in research and development of nutritional food products.  In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public.  Nutranomics has also produced formulas for hundreds of other companies.  Nutranomics' mission is to increase human health and longevity through education and self-awareness.  The Company has sales representatives throughout North America and Asia.  Learn more about Nutranomics at

For further information regarding Nutranomics, Inc., please contact our investor relations representatives at, or call toll-free (888) 616-3999.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements."  Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.  Actual results could differ from those projected in any forward-looking statements due to numerous factors.  Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions.  These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States.  Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.  Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at  These statements have not been evaluated by the Food and Drug Administration.  These products are not intended to diagnose, treat, cure or prevent any disease.

SOURCE Nutranomics, Inc.